These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30372025)

  • 1. Combating a Master Manipulator: Staphylococcus aureus Immunomodulatory Molecules as Targets for Combinatorial Drug Discovery.
    Rakesh KP; Marichannegowda MH; Srivastava S; Chen X; Long S; Karthik CS; Mallu P; Qin HL
    ACS Comb Sci; 2018 Dec; 20(12):681-693. PubMed ID: 30372025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases.
    Zecconi A; Scali F
    Immunol Lett; 2013 Feb; 150(1-2):12-22. PubMed ID: 23376548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of Staphylococcus aureus infections].
    Cotar AI
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):69-77. PubMed ID: 20422921
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection.
    Park B; Liu GY
    Semin Immunopathol; 2012 Mar; 34(2):299-315. PubMed ID: 22089960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus.
    Li Z; Mao R; Teng D; Hao Y; Chen H; Wang X; Wang X; Yang N; Wang J
    Sci Rep; 2017 Sep; 7(1):12124. PubMed ID: 28935900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.
    Choe H; Narayanan AS; Gandhi DA; Weinberg A; Marcus RE; Lee Z; Bonomo RA; Greenfield EM
    Clin Orthop Relat Res; 2015 Sep; 473(9):2898-907. PubMed ID: 25953690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson.
    Fedtke I; Götz F; Peschel A
    Int J Med Microbiol; 2004 Sep; 294(2-3):189-94. PubMed ID: 15493829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate Immune Signaling Activated by MDR Bacteria in the Airway.
    Parker D; Ahn D; Cohen T; Prince A
    Physiol Rev; 2016 Jan; 96(1):19-53. PubMed ID: 26582515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonconventional Therapeutics against
    Grunenwald CM; Bennett MR; Skaar EP
    Microbiol Spectr; 2018 Nov; 6(6):. PubMed ID: 30547858
    [No Abstract]   [Full Text] [Related]  

  • 10. Staphylococcus aureus evasion of innate antimicrobial defense.
    Kraus D; Peschel A
    Future Microbiol; 2008 Aug; 3(4):437-51. PubMed ID: 18651815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus: setting its sights on the human innate immune system.
    Buchan KD; Foster SJ; Renshaw SA
    Microbiology (Reading); 2019 Apr; 165(4):367-385. PubMed ID: 30625113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils in innate host defense against Staphylococcus aureus infections.
    Rigby KM; DeLeo FR
    Semin Immunopathol; 2012 Mar; 34(2):237-59. PubMed ID: 22080185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The redesign of oxazolidinone antibiotics in response to Staphylococcus aureus.
    Lupton D; Belousoff MJ
    Future Microbiol; 2017 Oct; 12():1113-1117. PubMed ID: 28876083
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive review.
    Gopikrishnan M; Haryini S; C GPD
    J Basic Microbiol; 2024 May; 64(5):e2300579. PubMed ID: 38308076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
    Cameron DR; Howden BP; Peleg AY
    Clin Infect Dis; 2011 Sep; 53(6):576-82. PubMed ID: 21865195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus strategies to evade the host acquired immune response.
    Goldmann O; Medina E
    Int J Med Microbiol; 2018 Aug; 308(6):625-630. PubMed ID: 28939437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of bi-component leukocidin and drug resistance in nasal and clinical Staphylococcus aureus in Lagos, Nigeria.
    Enwuru NV; Adesida SA; Enwuru CA; Ghebremedhin B; Mendie UE; Coker AO
    Microb Pathog; 2018 Feb; 115():1-7. PubMed ID: 29246634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Small-Molecule Inhibitor of Iron-Sulfur Cluster Assembly Uncovers a Link between Virulence Regulation and Metabolism in Staphylococcus aureus.
    Choby JE; Mike LA; Mashruwala AA; Dutter BF; Dunman PM; Sulikowski GA; Boyd JM; Skaar EP
    Cell Chem Biol; 2016 Nov; 23(11):1351-1361. PubMed ID: 27773628
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Löffler B; Tuchscherr L
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33921743
    [No Abstract]   [Full Text] [Related]  

  • 20. Host defense and pathogenesis in Staphylococcus aureus infections.
    DeLeo FR; Diep BA; Otto M
    Infect Dis Clin North Am; 2009 Mar; 23(1):17-34. PubMed ID: 19135914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.